Please assess the completion status of the following clinical trial:

Trial Title: A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18~* Prior non-hematogenous, histologically proven malignancy (specific exclusions are multiple myeloma and lymphoma)~* Pain attributable to one or two radiographically apparent metastatic lesion(s) amenable to ESRT~* Have had prior radiation to area of spine felt to be cause of patient's pain~* Zubrod performance status of 0-3~* Life expectancy of ≥ 3 months~* Signed informed consent prior to registration to study~* Radiographic evidence of stable disease outside of the spinal column for at least 6 weeks prior to study entry, as evaluated by pre-study imaging.~Exclusion Criteria:~* Women who are pregnant or nursing~* Either 'no evidence of other active cancerous disease' or 'other sites of known disease are locally controlled'~* No radiographic evidence of spinal instability (e.g. spinal cord compression requiring immediate surgical intervention)~* No initiation of chemotherapy within 15 days of trial entry.~* No plans for concomitant antineoplastic therapy (including standard fractionated RT, chemotherapy, biologic, vaccine therapy, or surgery) for at least 15 days following stereotactic radiosurgery.~* No active systemic infection.~* No evidence of myelopathy or cauda equina syndrome on clinical evaluation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group -1 (Type: EXPERIMENTAL): 1000 cGY radiation
- Group 1 (Type: EXPERIMENTAL): 1200 cGY radiation
- Group 2 (Type: EXPERIMENTAL): 1400 cGY radiation
- Group 3 (Type: EXPERIMENTAL): 1600 cGY radiation

Based on this trial design, predict the completion outcome and termination type (if applicable).